Covered recipient · General Payments record
MELISSA A CEBALLOS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2023
$907.02
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $417.62 | 24 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $207.12 | 12 |
| Merck Sharp & Dohme Corporation | $38.54 | 2 |
| Amgen Inc. | $34.57 | 2 |
| Lilly USA, LLC | $21.53 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.91 | 1 |
| Organon LLC | $18.84 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.99 | 1 |
| Acerta Pharma LLC | $16.35 | 1 |
| Astellas Pharma US Inc | $14.82 | 1 |
| Novo Nordisk AS | $14.17 | 1 |
| Exact Sciences Corporation | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.44 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372697 | CMS |
| ABBVIE INC. | $4.88 | 01/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372701 | CMS |
| ABBVIE INC. | $13.26 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372705 | CMS |
| ABBVIE INC. | $16.11 | 04/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372709 | CMS |
| ABBVIE INC. | $23.34 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372713 | CMS |
| ABBVIE INC. | $12.58 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372717 | CMS |
| ABBVIE INC. | $17.60 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372721 | CMS |
| ABBVIE INC. | $5.98 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372725 | CMS |
| ABBVIE INC. | $22.59 | 08/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372729 | CMS |
| ABBVIE INC. | $28.13 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372733 | CMS |
| ABBVIE INC. | $28.13 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372737 | CMS |
| ABBVIE INC. | $11.08 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003372741 | CMS |
| Amgen Inc. | $18.62 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020781363 | CMS |
| Amgen Inc. | $15.95 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020781365 | CMS |
| Astellas Pharma US Inc | $14.82 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033877605 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.35 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015760947 | CMS |
| Exact Sciences Corporation | $13.78 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026871939 | CMS |
| Lilly USA, LLC | $21.53 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033386507 | CMS |
| Merck Sharp & Dohme LLC | $19.05 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048280593 | CMS |
| Merck Sharp & Dohme LLC | $19.49 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048912667 | CMS |
| Novo Nordisk Inc | $14.17 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002519323 | CMS |
| Organon LLC | $18.84 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046926029 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.91 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057433753 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.99 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055758733 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.